Accredited Continuing Education Since 1983
Medical Courses:AnesthesiologyAIDS - Risk ManagementCardiologyEmergency MedicineFamily PracticeGastroenterologyGeriatricsInternal MedicineNeurologyOB/GYNOncologyOphthalmologyOrthopedicsOtolaryngologyPediatricsPsychiatrySurgeryTraumaUrology |
Oncology CME CourseFull Course - 20 Credits/$490.00 • Short Course - 10 Credits/$395.00
Oncology
onc
OncologyBreast Cancer Today Anna Marie Wallace, Rosemary Leeming, and Stephen B. Edge Compare the options for biopsy in a patient with breast cancer; Utilize the current recommendations for staging a patient with breast cancer; Describe the options for breast cancer imaging in benign breast disease; Discuss the pathophysiology, clinical features, and management of benign breast disease; and Take advantage of the programs currently available for improving the quality of care in breast cancer patients.
Melanoma and Incidentaloma David J. Cole, David R. Farley, and Richard Essner Describe anatomic classifications and microstaging systems for melanoma; Determine appropriate excisional margins for melanoma lesions; Identify patients for whom sentinel lymph node biopsy or therapeutic lymph node resections is appropriate; Identify patients likely to benefit from surgical management of adrenal incidentalomas and discuss the recommendations for open and laparoscopic approaches; and Compare the surgical and nonsurgical options for treating patients with melanoma.
Rectal Cancer David A. Rothenberger, Thomas E. Read, and D. Scott Lind Discuss the recurrence of rectal cancer following initial treatment; Summarize the methodologies used in evaluating patients for surgery; Review the surgical and adjunctive treatment plans; Explain the variables affecting rectal cancer treatment; and List and explain the different surgical options.
Cancer: Part 1 Alex G. Little and Larry C. Carey Determine which test is most useful in staging adenocarcinoma of the GEJ; Describe the carious surgical approaches appropriate for caner of the GEJ; Discuss methods of palliation for periampullary tumors; Utilize narcotics appropriately for palliation; and Recognize when surgery is necessary for pancreatic cystic tumors.
Cancer: Part 2 Michael Bouvet and Steven C. Rose Identify the different neuroendocrine tumors of the pancreas and list modalities for their localization; Summarize the treatment options for neuroendocrine tumors; Describe the therapeutic options for patients with HCC; Discuss transcatheter arterial chemoembolization and selective internal radiation therapy as regional therapy for patients with HCC; and Compare alcohol injections and radiofrequency ablation as focal ablative therapy for patients with HCC.
Breast Cancer Screening Jodi Friedman Identify women at risk of developing breast cancer; Summarize and evaluate trial data on the efficacy of breast cancer detection modalities; Select the most appropriate breast cancer screening protocol for each patient; Assess risk-reduction options for patients at high risk for breast cancer; and Summarize trail data evaluating tamoxifen and raloxifene for the prevention of breast cancer.
Issues in Cervical Cancer Prevention Levi S. Downs and Sharon Bond Discuss the natural history of HPV infection; Determine the effectiveness of the currently licensed HPV vaccine; Identify appropriate patients for vaccination with the HPV vaccine; Determine when to begin and when to discontinue Pap testing; and Manage patient with Pap test abnormalities.
Prostate Cancer: Questions and Answers Phillip L. Ross. Peter Carroll, Mack Roach, III, and Charles J. Ryan Discuss critical issues surrounding the use of chemoprevention; Review current avenues for administering chemopreventive therapy; Evaluate the potential risks and benefits associated with active surveillance; Determine when and how long patients should receive a combination of radiation and hormone therapy; and Tace the evolution of the current definition of high-risk prostate cancer.
New Frontiers in Prostate Cancer Management E. David Crawford and David C. Beyer Discuss the role of targeted therapy in the management of hormone refractory prostate cancer; Describe concepts underlying active cellular immunotherapy with sipuleucel-T and targeted small molecule therapy using atrasentan; Explore correlations in demographic and clinical data between prostate cancer and breast cancer; Assess the clinical merits of early hormonal therapy in the management of breast cancer; and Determine the present and future role of robotic surgery in prostate cancer management.
|